(Q53581804)

15 May 2018

title

Health-related quality of life associated with lower urinary tract symptoms in four countries. (English)

1 reference

15 May 2018

1 reference

2

1 reference

15 May 2018

Peter Boyle

9

1 reference

15 May 2018

Michael M. Lieber

10

object named as

Lieber MM

1 reference

15 May 2018

Cynthia J Girman

1

object named as

Girman CJ

1 reference

15 May 2018

author name string

Tsukamoto T

3

1 reference

15 May 2018

Richard F

4

1 reference

15 May 2018

Garraway WM

5

1 reference

15 May 2018

Sagnier PP

6

1 reference

15 May 2018

Guess HA

7

1 reference

15 May 2018

Rhodes T

8

1 reference

15 May 2018

language of work or name

English

0 references

publication date

1 March 1998

1 reference

15 May 2018

published in

Urology

1 reference

15 May 2018

volume

51

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

428-436

1 reference

15 May 2018

Benign Prostatic Hyperplasia: Antecedents and Natural History

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

New words for old: lower urinary tract symptoms for "prostatism"

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Quality of life assessment for evaluating benign prostatic hyperplasia treatments. An example of using a condition-specific index.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Urinary symptom and quality of life questions indicative of obstructive benign prostatic hyperplasia. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Patient Reports of Symptoms and Quality of Life following Prostate Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. The Department of Veterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Benign prostatic hyperplasia: effects on quality of life and impact on treatment decisions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Long-term quality of life in patients with benign prostatic hypertrophy: preliminary results of a cohort survey of 7,093 patients treated with an alpha-1-adrenergic blocker, alfuzosin. QOL BPH Study Group in General Practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hyperplasia. Finasteride Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Impact of benign prostatic hyperplasia on general well-being of men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Impact of Symptoms of Prostatism on Level of Bother and Quality of Life of Men in the French Community

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Urinary symptoms: prevalence and severity in British men aged 55 and over

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Urinary symptoms in the community: how bothersome are they?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Prevalence of urinary symptoms in men aged over 60.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Analysis of the prevalence of voiding symptoms in Maori, Pacific Island, and Caucasian New Zealand men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Epidemiology of Bladder Emptying Symptoms in Elderly Men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Obstructive prostatic symptoms: a community survey in Jerusalem

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Prevalence and detection of micturition problems among 2,734 elderly men

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Natural history of prostatism: impaired health states in men with lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Natural history of prostatism: worry and embarrassment from urinary symptoms and health care-seeking behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Natural history of prostatism: Factors associated with discordance between frequency and bother of urinary symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

The prevalence of prostatism: a population-based survey of urinary symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

High prevalence of benign prostatic hypertrophy in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

International comparison of the community prevalence of symptoms of prostatism in four countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Validation of a new quality of life questionnaire for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

The natural history of prostatism: the effects of non-response bias.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Adverse effects of medications on urinary symptoms and flow rate: a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Benign prostatic hyperplasia and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

A cross-cultural comparison of health status values

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Does the mode of questionnaire administration affect the reporting of urinary symptoms?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

The American Urological Association symptom index: does mode of administration affect its psychometric properties?

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Epidemiology of benign prostatic hyperplasia: present knowledge and studies needed.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900717-6

7 January 2021

10.1016/S0090-4295(97)00717-6

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018